share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Mar 29 04:31

Gainers

  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million.
  • Sunshine Biopharma (NASDAQ:SBFM) shares increased by 37.85% to $0.08. The market value of their outstanding shares is at $8.2 million.
  • Dare Bioscience (NASDAQ:DARE) stock rose 12.19% to $0.55. The company's market cap stands at $54.2 million. As per the news, the Q4 earnings report came out today.
  • Xilio Therapeutics (NASDAQ:XLO) shares moved upwards by 9.36% to $1.2. The company's market cap stands at $33.0 million.
  • Talphera (NASDAQ:TLPH) stock rose 8.73% to $1.12. The market value of their outstanding shares is at $19.0 million.
  • Zentalis Pharma (NASDAQ:ZNTL) shares increased by 8.62% to $17.12. The company's market cap stands at $1.2 billion.

Losers

  • Vivos Therapeutics (NASDAQ:VVOS) stock fell 12.6% to $4.22 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million. As per the news, the Q4 earnings report came out today.
  • Cartesian Therapeutics (NASDAQ:RNAC) stock declined by 12.31% to $0.57. The market value of their outstanding shares is at $92.3 million.
  • Pulse Biosciences (NASDAQ:PLSE) stock decreased by 11.37% to $7.72. The company's market cap stands at $425.2 million. The company's, Q4 earnings came out today.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 9.27% to $1.47. The market value of their outstanding shares is at $6.2 million.
  • BiomX (AMEX:PHGE) stock fell 8.89% to $0.41. The company's market cap stands at $18.8 million.
  • Iridex (NASDAQ:IRIX) stock decreased by 8.28% to $2.77. The company's market cap stands at $45.0 million. As per the news, the Q4 earnings report came out 2 days ago.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment